COMP <GO>
DNLI vs TARS // EV/EBITDA & P/E VALUATION
Denali Therapeutics Inc. (NASDAQ) VS. Tarsus Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: DNLI 1
— TARS 5
■ METRIC PARITY
LAST: $19.32 (+0.16%) • MKT CAP: $3.09B
valuation
—
LAST: $74.20 (+2.98%) • MKT CAP: $3.66B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DNLI VS. TARS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | DNLI | TARS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -24.10% | -10.90 | TARS | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -13.67% | -0.61% | -13.06 | TARS | /fcf-yield <GO> |
| Operating Margin | — | -15.70% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -14.60% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 146.70% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 10.87 | 10.19 | +0.68 | DNLI | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 5/9 | -3.00 | TARS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.3 | 55.1 | -9.83 | TARS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.09B | $3.66B | -$570.1M | TARS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | DNLI REV | TARS REV | DNLI GROSS % | TARS GROSS % | DNLI FCF | TARS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $451.4M | — | — | -$422.1M | -$22.3M |
| FY 2024 | $0 | $183.0M | — | — | -$363.6M | -$84.6M |
| FY 2023 | $330.5M | $17.4M | — | — | -$358.0M | -$117.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DNLI // BETA —
TARS // BETA —